Enveric Biosciences (NASDAQ:ENVB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Enveric Biosciences (ENVB) operate in?

Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.

Open	$0.34
Close	$0.33
Volume / Avg.	123.00K / 503.31K
Day Range	$0.33 - $0.36
52 Wk Range	0.31 - 2.92
Market Cap	$3.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	3.34%
Days to Cover	1

Recent News

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders

Nina Zdinjak

Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal

Enveric licenses EB-002 to MycoMedica for neuropsychiatric treatment, focusing on EB-003's development with potential milestones up to $62M.

Franca Quarneti

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.34
Close	$0.33
Volume / Avg.	123.00K / 503.31K
Day Range	$0.33 - $0.36
52 Wk Range	0.31 - 2.92
Market Cap	$3.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	3.34%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Enveric Biosciences (ENVB) stock?

You can purchase shares of Enveric Biosciences (NASDAQ:ENVB) through any online brokerage.

View our list of the best stock brokerages

Who are Enveric Biosciences (ENVB) competitors?

Other companies in Enveric Biosciences’s space includes: Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP) and cbdMD (AMEX:YCBD).

What is the forecast, or price target, for Enveric Biosciences (ENVB) stock?

Enveric Biosciences has a consensus price target of $3.82.

What is the current price for Enveric Biosciences (ENVB)?

The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.3176 last updated November 22, 2024 at 7:59 PM EST.

Does Enveric Biosciences (ENVB) pay a dividend?

There are no upcoming dividends for Enveric Biosciences.

When is Enveric Biosciences (NASDAQ:ENVB) reporting earnings?

Enveric Biosciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is Enveric Biosciences (ENVB) going to split?

There is no upcoming split for Enveric Biosciences.

What sector and industry does Enveric Biosciences (ENVB) operate in?

Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Enveric Biosciences

Enveric Biosciences (ENVB) Forecast